Global Laboratory-developed Testing Market Growth: Industry Size, Analysis and Forecast
Report ID : 1333208 | Published : February 2025 | Study Period : 2023-2033 | Format : PDF + Excel
The market size of the Laboratory-developed Testing Market is categorized based on Test Type (Genetic Testing, Infectious Disease Testing, Oncology Testing, Cardiovascular Testing, Other Tests) and End User (Hospitals, Diagnostic Laboratories, Research Institutions, Pharmaceutical Companies, Other End Users) and Sample Type (Blood Samples, Tissue Samples, Urine Samples, Saliva Samples, Other Sample Types) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).
The market size of Laboratory-developed Testing Market, valued at USD 6.5 billion in 2023, is projected to reach USD 12.8 billion by 2033, expanding at a CAGR of 7.2% between 2024 and 2033. The report comprises various segments and analyzes significant trends and factors influencing market growth.
The Laboratory-developed Testing (LDT) market addresses distinct needs within the healthcare ecosystem as a segment that seeks out new diagnostic opportunities. It is essential to note that this particular segment is constantly evolving. With the constant progression of technology, LDTs have come to be viewed as an indispensable resource for clinicians, as these tests offer the ability to design customized solutions for specific medical conditions as well as take into consideration the nuances of the patient’s demographic. Such flexibility facilitates improved diagnostic accuracy and personalized medicine, resulting in the move toward more precise and effective treatment methods.
Increased technological advancement has led to a better understanding of human health which has resulted in a rise in the demand for laboratory-developed tests in recent years. These tests are particularly useful in oncology, genetics, and infectious diseases, where more conventional forms of testing are inadequate. Further, the LDT market is poised for rapid growth as well as innovation, especially when laboratories are looking to expand their capabilities and improve upon meeting regulatory requirements. This is what makes the LDT market the center for attention in modern healthcare.
| ATTRIBUTES | DETAILS |
| STUDY PERIOD | 2023-2033 |
| BASE YEAR | 2023 |
| FORECAST PERIOD | 2024-2033 |
| HISTORICAL PERIOD | 2023-2024 |
| UNIT | VALUE (USD BILLION) |
| KEY COMPANIES PROFILED | LabCorp, Quest Diagnostics, Roche Diagnostics, Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, PerkinElmer, Mayo Clinic Laboratories, Invitae Corporation, Genomic Health, Myriad Genetics |
| SEGMENTS COVERED |
By Test Type - Genetic Testing, Infectious Disease Testing, Oncology Testing, Cardiovascular Testing, Other Tests
By End User - Hospitals, Diagnostic Laboratories, Research Institutions, Pharmaceutical Companies, Other End Users
By Sample Type - Blood Samples, Tissue Samples, Urine Samples, Saliva Samples, Other Sample Types
By Geography - North America, Europe, APAC, Middle East Asia & Rest of World. |
Laboratory-developed Testing Market Dynamics
The Laboratory-developed Testing Market is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.
Market Drivers
- Technological Advancements
- Increasing Consumer Demand
- Regulatory Support
- Globalization
Market Restraints
- High Operational Costs
- Regulatory Challenges
- Market Saturation
Market Opportunities
- Emerging Markets
- Product Innovation
- Strategic Partnerships
Market Challenges
- Technological Disruptions
- Supply Chain Issues
- Changing Consumer Preferences
Laboratory-developed Testing Market Segmentations
Market Breakup by Test Type
- Overview
- Genetic Testing
- Infectious Disease Testing
- Oncology Testing
- Cardiovascular Testing
- Other Tests
Market Breakup by End User
- Overview
- Hospitals
- Diagnostic Laboratories
- Research Institutions
- Pharmaceutical Companies
- Other End Users
Market Breakup by Sample Type
- Overview
- Blood Samples
- Tissue Samples
- Urine Samples
- Saliva Samples
- Other Sample Types
Market Breakup by Region
North America
- United States of America
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Players in the Laboratory-developed Testing Market
This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.
- LabCorp
- Quest Diagnostics
- Roche Diagnostics
- Thermo Fisher Scientific
- Abbott Laboratories
- Danaher Corporation
- PerkinElmer
- Mayo Clinic Laboratories
- Invitae Corporation
- Genomic Health
- Myriad Genetics
Customization Options
Verified Industry Insights offers one of the following report customization options to our respectable clients :
Company Profiling
● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)
Competitive Benchmarking
● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research
Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439
© 2024 Verified Industry Insights. All Rights Reserved